Latest Breaking News On - Adagio medical inc - Page 1 : vimarsana.com

Adagio Medical, Inc.: Adagio Medical Announces First European Commercial Procedures and Commencement of U.S. FDA Pivotal IDE for Ventricular Tachycardia Cryoablation System

ARYA Sciences Acquisition IV : Failure to Satisfy Listing Rule - Form 8-K -March 29, 2024 at 06:19 am EDT

Item 3.01. Notice of Delisting or Failure to Satisfy a Continued Listing Rule or...

Adagio Medical Announces CE Mark approval of VT Cryoablation System, Plans for Immediate Commercialization in Select European Centers

Adagio Medical, Inc., a leading innovator in catheter ablation technologies for ventricular tachycardia ("VT") and atrial fibrillation ("AF"), today announced CE Mark approval of its ultra-low temperature cryoablation ("ULTC") system for the treatment of monomorphic ventricular tachycardia. The system consists of the upgraded cryoablation console, also capable of supporting atrial ablation procedures using commercially available iCLAS™ catheters, and the vCLAS™ ventricular cryoablation catheter

Adagio Medical, Inc.: Adagio Medical Announces CE Mark approval of VT Cryoablation System, Plans for Immediate Commercialization in Select European Centers

Adagio speeds up financing rhythm with $42M SPAC deal

The slow pace of financing in med-tech appears to have stimulated cardiac arrhythmia technology developer Adagio Medical Inc. to turn to a special purpose acquisition company (SPAC) in a type of deal that has all but vanished in the last year. The company signed an agreement with Arya Sciences Acquisition Corp. IV to combine in a reverse merger deal that will result in Adagio’s listing on Nasdaq under “ADGM.”

Adagio Medical, Inc.: Adagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation Technologies

Adagio Medical to Go Public via Merger with ARYA Sciences Acquisition Corp IV (ARYD)

Adagio Medical Set To List On Nasdaq Through SPAC Deal With ARYA Sciences

Adagio Medical, Inc., a privately held innovator in catheter ablation technologies for treatment of cardiac arrhythmias, announced Wednesday a definitive agreement with ARYA Sciences Acquisition Corp IV (ARYD), a special purpose acquisition company sponsored by an affiliate of Perceptive Advisors, LLC, for a business combination.

Adagio Medical To List on Nasdaq Through Business Combination with ARYA Sciences Acquisition Corp IV, Enabling Further Commercial and Clinical Development of Innovative Cardiac Ablation Technologies

Electrophysiology Ablation Catheters Pipeline 2023:

Dublin, Oct. 26, 2023 (GLOBE NEWSWIRE) -- The